NASHUA, N.H. (November 2, 2016) – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of
advanced image analysis, workflow solutions and radiation therapy for the early identification and
treatment of cancer, today reported financial results for the three and nine months ended September 30,
2016.

Full Release